PDK4 and ovarian dysfunction: Our findings provide the rationale for PDK4 as a key and potential therapeutic target to ameliorate and preserve the competence of oocytes, and support the application of putrescine to slow the oxidative stress-mediated aging of oocytes and ovarian dysfunction.